Skip to content
Search

Latest Stories

3 in 5 cancer patients in England now diagnosed at early stage - NHS analysis

Early cancer diagnosis in England has reached its highest level ever.
Colon cancer blood test, conceptual image. (gettyimages)

The TLHC programme led to the earlier diagnosis of over 5,000 people with lung cancer since its launch in 2019

More cancers are being detected earlier in England, thanks to a major drive by the NHS encouraging people, particularly those at higher risk due to hereditary or lifestyle factors, to come forward for potentially life-saving screenings.

According to a new NHS analysis, early cancer diagnosis in England has reached its highest level ever.


The NHS data of the most common cancers, including breast, prostate, and lung cancer, shows that almost three in five patients are now being diagnosed at stages one or two, when the cancer is more treatable.

More than 58 per cent of all common cancers (206,038) diagnosed between September 2023 and August 2024 were identified at an early stage.

This marks a 2.7 percentage point improvement compared to pre-pandemic levels, equating to an estimated 7,000 more patients being diagnosed at an early stage.

The NHS has introduced initiatives like the Targeted Lung Health Check (TLHC) and Liver Health Programmes to detect cancers earlier.

These programmes use mobile scanning trucks and vans that go into the heart of communities, offering in-depth checks to people at shopping centres, sports stadiums, food banks and supermarket car parks.

Since its launch in 2019, the TLHC programme has led to the earlier diagnosis of over 5,000 people with lung cancer, NHSE data reveals.

“Lives are saved when cancers are caught early,” said Dame Cally Palmer, national cancer director for NHS England, highlighting the benefits of the early cancer detection drive.

“There is still much more to do to save more lives and we will not let up in our efforts to catch more cancers earlier, where treatment is more likely to be successful.”

“NHS teams across the country are continuing to take tests and checks closer to people who need them, and with new treatments being made available all the time, we will continue to do all we can to get people seen and treated for cancer as early as possible,” he added.

Professor Peter Johnson, NHS England’s national clinical director for cancer, noted that as life expectancy increases and the number of people developing cancer continues to rise, the NHS diagnosing more cancers than ever before.

He encourages people who suspect they might have signs or symptoms of cancer to get checked so that they can get treatment promptly.

According to Cancer Research UK, lung cancer is the most common cause of cancer death in the UK, accounting for about 21 per cent of all cancer deaths in females and males combined (2017-2019). The next most common causes of cancer death are bowel cancer (10 per cent ), followed by prostate cancer, and breast cancer (both responsible for about seven per cent of all cancer fatalities).

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less